MEDEFILE INTERNATIONAL, INC.
301 Yamato Road, Suite 315
Boca Raton, FL 33431
August 15, 2011
VIA EDGAR
Division of Corporate Finance
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549-3561
| Attn: | Mark P. Shuman, Legal Branch Chief |
Jan Woo, Staff Attorney
Dear Mr. Shuman:
This is to confirm that, in its future 10-K and 10-Q filings, Medefile International, Inc. (the “Company”) will, in accordance with Compliance and Disclosure Interpretations Section 204.05:
| · | Leave blank both boxes to the question “Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.” |
| · | Include an “explanatory note” disclosing (i) that the Company is not subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, and files reports with the SEC voluntarily, and (ii) (if true) that the Company has filed all Exchange Act reports for the preceding 12 months. |
We acknowledge that:
| · | The Company is responsible for the adequacy and accuracy of the disclosures in the filings; |
| · | Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filings; and |
| · | The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
| | | |
| | | | |
| | By: | /s/ Kevin Hauser | |
| | | Kevin Hauser | |
| | | President and Chief Executive Officer | |
| | | | |
